Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Harding

Showing results (851-860 of 945) with videos related to

Pageof 95
Sort By:
Journal of Medicinal Chemistry|July 27, 2023
Discovery and Characterization of a Chemical Probe Targeting the Zinc-Finger Ubiquitin-Binding Domain of HDAC6Rachel J Harding, Ivan Franzoni, Mandeep K Mann, et al.
Communications Biology|December 9, 2021
Huntingtin structure is orchestrated by HAP40 and shows a polyglutamine expansion-specific interaction with exon 1Rachel J Harding, Justin C Deme, Johannes F Hevler, et al.
The Journal of Clinical Investigation|July 23, 2019
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumorsDanny N Khalil, Nathan Suek, Luis Felipe Campesato, et al.
Cancer Medicine|April 16, 2023
Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survivalKevin C Soares, Joshua S Jolissaint, Sarah M McIntyre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2024
A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome ClassifierYi Song, Thomas Boerner, Esther Drill, et al.
Plos Pathogens|November 8, 2012
Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen moleculesSteven Johnson, Lionel Tan, Stijn van der Veen, et al.
Diabetes & Metabolism|June 4, 2015
The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?J Harding, M Sooriyakumaran, K J Anstey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 19, 2020
Characterization of on-target adverse events caused by TRK inhibitor therapyD Liu, J Flory, A Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2026
High-throughput protein target mapping enables accelerated bioactivity discovery for ToxCast and PFAS compoundsDiwen Yang, Xiaoyun Wang, Jiabao Liu, et al.
Journal of Chemical Information and Modeling|May 26, 2025
Active Learning-Guided Hit Optimization for the Leucine-Rich Repeat Kinase 2 WDR Domain Based on In Silico Ligand-Binding AffinitiesFilipp Gusev, Evgeny Gutkin, Francesco Gentile, et al.
Pageof 95

Showing results (851-860 of 945) with videos related to

Sort By:
Pageof 95
Journal of Medicinal Chemistry|July 27, 2023
Discovery and Characterization of a Chemical Probe Targeting the Zinc-Finger Ubiquitin-Binding Domain of HDAC6Rachel J Harding, Ivan Franzoni, Mandeep K Mann, et al.
Communications Biology|December 9, 2021
Huntingtin structure is orchestrated by HAP40 and shows a polyglutamine expansion-specific interaction with exon 1Rachel J Harding, Justin C Deme, Johannes F Hevler, et al.
The Journal of Clinical Investigation|July 23, 2019
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumorsDanny N Khalil, Nathan Suek, Luis Felipe Campesato, et al.
Cancer Medicine|April 16, 2023
Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survivalKevin C Soares, Joshua S Jolissaint, Sarah M McIntyre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2024
A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome ClassifierYi Song, Thomas Boerner, Esther Drill, et al.
Plos Pathogens|November 8, 2012
Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen moleculesSteven Johnson, Lionel Tan, Stijn van der Veen, et al.
Diabetes & Metabolism|June 4, 2015
The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?J Harding, M Sooriyakumaran, K J Anstey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 19, 2020
Characterization of on-target adverse events caused by TRK inhibitor therapyD Liu, J Flory, A Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2026
High-throughput protein target mapping enables accelerated bioactivity discovery for ToxCast and PFAS compoundsDiwen Yang, Xiaoyun Wang, Jiabao Liu, et al.
Journal of Chemical Information and Modeling|May 26, 2025
Active Learning-Guided Hit Optimization for the Leucine-Rich Repeat Kinase 2 WDR Domain Based on In Silico Ligand-Binding AffinitiesFilipp Gusev, Evgeny Gutkin, Francesco Gentile, et al.
Pageof 95